Bilacon receives GAFTA certification – another milestone for quality and safety in food and feed analysis
We are pleased to announce that bilacon, a leading laboratory of the Tentamus Group, has successfully achieved GAFTA (Gr…
Bilacon erhält GAFTA-Zertifizierung – Ein weiterer Meilenstein für Qualität und Sicherheit in der Lebens- und Futtermittelanalytik
Wir freuen uns, bekannt zu geben, dass bilacon, ein führendes Labor der Tentamus Group, erfolgreich die GAFTA-Zertifizie…
Tentamus Group reinforces its commitment to Central and Southern Italy
The Tentamus Group Italy announces the merger between MK’s headquarters in Città di Castello and Tentamus Agriparadigma,…
VelaLabs Announces Strategic Partnership with EarlyHealth Group to Support Biological Drugs Development
VelaLabs GmbH, a leading provider of analytical and quality services for biopharmaceutical development, has signed a Mem…
Established Products and New Limits in Agrochemicals and Biocides
The global focus on green agrochemistry and the health of consumers and operators continues to grow, driving significant…
EPL Bio Analytical Services and EpiLogic GmbH Partner to Offer Plant Fungal Pathogen testing services in North America
EPL Bio Analytical Services, a Tentamus company, is excited to announce a partnership with our German sister lab EpiLogi…
Legal Requirements for Cannabis Social Clubs (CSCs)
Quality control of consumer cannabis is essential to bringing flawless products to the market. It requires careful monitoring and testing at all stages of production - from seed to final product.
Rechtliche Anforderungen für Anbauvereinigungen (CSCs)
Qualitätskontrolle bei Konsumcannabis ist essenziell, um einwandfreie Produkte auf den Markt zu bringen. Sie erfordert eine sorgfältige Überwachung und Prüfung in allen Produktionsphasen – vom Samen bis zum Endprodukt.
Inspiration und Networking pur: Tentaconsult zieht positives Fazit zur MEDICA 2024!
Tentaconsult blickt auf einen äußerst erfolgreichen Auftritt auf der MEDICA 2024 zurück. Als Teil des Gemeinschaftsstand…
Changing medical device market: challenges and opportunities through MDR adaptations!
Alongside the pharmaceutical industry, the German medical technology sector, with an annual turnover of 40.4 billion euros and an export rate of 68%, is another mainstay of the German economy and represents an important part of national healthcare. However, since Regulation (EU) 2017/745, known as the Medical Device Regulation (MDR), came into force, the industry has faced considerable financial and capacity-related challenges.
